Jazz Pharmaceuticals plc buy Cantor Fitzgerald
Start price
29.02.24
/
50%
€109.90
Target price
28.02.25
€166.54
Performance (%)
-5.87%
Price
07.05.24
€103.45
Summary
This prediction is currently active. With a performance of -5.87%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | -0.337% | -0.337% |
iShares Core DAX® | 2.831% | 1.236% |
iShares Nasdaq 100 | 2.918% | 0.640% |
iShares Nikkei 225® | 2.007% | -2.135% |
iShares S&P 500 | 2.257% | 0.451% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $180.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€106.15
10.04.24
10.04.24
€167.24
10.04.25
10.04.25
-2.54%
07.05.24
07.05.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€113.00
22.03.24
22.03.24
€166.54
22.03.25
22.03.25
-8.45%
07.05.24
07.05.24